About Anadys Pharma
Anadys Pharma is a company based in San Diego (United States) founded in 2001 was acquired by Roche in October 2011. Anadys Pharma has raised $38.3 million across 2 funding rounds from investors including Roche, China Developement Bank and Atlas Venture. Anadys Pharma offers products and services including Taneral Pro, Liftactive szérum, Lipofix csepp, Start Erotique gél, and Yes Lashes szérum. Anadys Pharma operates in a competitive market with competitors including Eiger BioPharmaceuticals, Aligos Therapeutics, AusperBio, Ascentage Pharma and Bluejay Therapeutics, among others.
- Headquarter San Diego, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Anadys Pharmaceuticals, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anadys Pharma
Anadys Pharma offers a comprehensive portfolio of products and services, including Taneral Pro, Liftactive szérum, Lipofix csepp, Start Erotique gél, and Yes Lashes szérum.
Magnetic belt for posture and body alignment correction.
Serum to reduce wrinkles around eyes and face.
Drops aimed at supporting weight reduction efforts.
Gel for enhancing sexual health and experiences.
Serum for promoting eyelash growth and length.
Funding Insights of Anadys Pharma
Anadys Pharma has successfully raised a total of $38.3M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.5 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Anadys Pharma
Anadys Pharma has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche, China Developement Bank and Atlas Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital firm investing in life science and biotechnology sectors
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Anadys Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Anadys Pharma
Investment portfolio details for Anadys Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Anadys Pharma
Detailed financials for Anadys Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anadys Pharma Comparisons
Peer comparison for Anadys Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Anadys Pharma
Anadys Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eiger BioPharmaceuticals, Aligos Therapeutics, AusperBio, Ascentage Pharma and Bluejay Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| Locked | Locked | Locked |
Developer of therapies to treat hepatologic diseases and viral infections
|
|
| Locked | Locked | Locked |
Therapies for chronic hepatitis B and infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Small molecule drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for infectious diseases treatment are developed.
|
|
| Locked | Locked | Locked |
Small-molecule antiviral therapeutics for hepatitis C are developed.
|
Detailed competitors of Anadys Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anadys Pharma
Complete news archive for Anadys Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anadys Pharma
Anadys Pharma was founded in 2001 and raised its 1st funding round 1 year after it was founded.
Anadys Pharma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Anadys Pharma is a funded company, having raised a total of $38.3M across 2 funding rounds to date.
Anadys Pharmaceuticals was founded in 2001 as a biopharmaceutical entity based in San Diego, United States. Focus is placed on developing treatments for chronic hepatitis C, with pipeline candidates including ANA598, a non-nucleoside polymerase inhibitor, and ANA773, an oral TLR7 agonist prodrug. Additional exploration of ANA773 occurs for oncology applications. Operations center on advancing these agents through clinical development stages.
Anadys Pharma's top competitors include Eiger BioPharmaceuticals, AusperBio and Finch Therapeutics.
Anadys Pharma offers Taneral Pro, Liftactive szérum, Lipofix csepp, Start Erotique gél, and Yes Lashes szérum.
Anadys Pharma has 12 investors. Key investors include Roche, China Developement Bank, Atlas Venture, HBM Healthcare Investments, and Care Capital.